Phase II study of rapid-scheduled etoposide in paediatric soft tissue sarcomas (Q71971502)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7640053%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

title

Phase II study of rapid-scheduled etoposide in paediatric soft tissue sarcomas (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7640053%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1 reference

M. B. Phillips

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7640053

5 July 2024

F. Flamant

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7640053

5 July 2024

D. Sommelet-Olive

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7640053

5 July 2024

C. R. Pinkerton

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7640053

5 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7640053

5 July 2024

publication date

1 January 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7640053%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

22 October 2019

https://api.elsevier.com/content/article/PII:095980499500092W?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00092-W

https://api.elsevier.com/content/article/PII:095980499500092W?httpAccept=text/plain

5 July 2024

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00092-W

European Journal of Cancer

5 July 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7640053%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

volume

31A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7640053%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7640053%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

page(s)

782-784

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7640053%20AND%20SRC:MED&resulttype=core&format=json

The Intergroup Rhabdomyosarcoma Study-II.

22 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00092-W

Treatment of soft tissue sarcoma in childhood and adolescence. A report of the German Cooperative Soft Tissue Sarcoma Study

5 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00092-W

Review of etoposide single-agent activity

5 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00092-W

Phase II study of VP-16-213 in childhood malignant disease: a Children's Cancer Study Group Report

5 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00092-W

In vitro cytotoxicity of VP 16 on primary tumor and metastasis of Lewis lung carcinoma

5 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00092-W

The effect of the two epipodophyllotoxin derivatives etoposide (VP-16) and teniposide (VM-26) on cell lines established from patients with small cell carcinoma of the lung

5 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00092-W

In vitro pharmacodynamic evaluation of VP-16-213 and implications for chemotherapy

5 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00092-W

A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer

5 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00092-W

An attempt to use a common staging system in rhabdomyosarcoma: a report of an international workshop initiated by the International Society of Pediatric Oncology (SIOP)

5 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00092-W

Rapid VAC high dose melphalan regimen, a novel chemotherapy approach in childhood soft tissue sarcomas

5 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00092-W

'MACHO' chemotherapy for stage IV B cell lymphoma and B cell acute lymphoblastic leukaemia of childhood. United Kingdom Children's Cancer Study Group (UKCCSG)

5 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00092-W

Successful management of metastatic and primary germ cell tumors in the brain

5 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00092-W

Intensive chemotherapy including cisplatin with or without etoposide for children with soft-tissue sarcomas

5 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00092-W

VP-16 alone and in combination with cisplatin in previously treated patients with small cell lung cancer

5 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00092-W

Pilot study of a rapid etoposide-cisplatin regimen in paediatric soft tissue sarcomas

5 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00092-W

Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia

5 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00092-W

5 July 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7640053%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1 reference